The Worldwide Epidemic: Global AIDS Picture Worsens; Global Infectious Causes of Death (Table); The Future of AIDS (Table; The Twilight of Eradication: Infectious HIV Persists After Up to 2 1/2 Years of Triple Drug Therapy
Would-Be Eradicatee Looks Forward to Still Uncertain Future; Data from the 23rd ACTG Meeting Document Reduction in Number of Opportunistic Infections in the Era of HAART; The Opportunistic Infections of ACTG 320
Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance; Metabolic Disturbances in HIV Infection Find Friend Not Foe in Protease Inhibitor Regimens; How the Triple Combos Stack Up
Panel Embraces Maximum Viral Suppression as Goal of Therapy; Drug Company Bonanza Creates Headaches for Third-Party Payers and AIDS Treatment Educators; Birth of a Paradigm
Always watch for outdated information. These articles first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor. TAGline is published monthly by the Treatment Action Group (TAG), a 501(c)(3) non-profit treatment advocacy organization in New York City. Copyright © 1997 - Treatment Action Group (TAG), 200 East 10th Street, #60, New York, NY 10003, phone: (212) 260-0300, fax: (212) 260-8561. All rights reserved. No part of this publication may be copied or reproduced in any form or by any means without the written permission of Treatment Action Group.